What does this video actually claim?
Mackenzie Berger is promoting a three-peptide combination she calls a 'glow stack': GHK-Cu, BPC-157, and TB-500. She claims this mix targets hormones, skin, and gut healing, specifically calling out people with PCOS and celiac disease.
The post suggests these peptides work synergistically for multiple health benefits. But peptide therapy isn't regulated like prescription drugs, and most of these compounds lack strong human clinical data.
Do these peptides actually work for PCOS and gut issues?
The evidence is thin to nonexistent for her specific claims. BPC-157 has shown promise in animal studies for gut healing, but human trials are limited. A 2020 review (Chang et al., Biomedicines) noted BPC-157's potential for GI tract repair in rodent models.
For PCOS specifically, there's no published research on any of these three peptides. GHK-Cu has some skin studies showing collagen production increases, but the connection to hormonal conditions like PCOS is unproven.
TB-500 (thymosin beta-4) has been studied for wound healing, but again, no human trials for gut or hormonal issues exist in peer-reviewed literature.
What's the regulatory status of these peptides?
Here's where things get murky. The FDA hasn't approved any of these peptides for the conditions Berger mentions. In fact, the FDA has been cracking down on compounding pharmacies selling research peptides for human use.
BPC-157 and TB-500 are often sold as 'research chemicals' with labels saying 'not for human consumption.' Yet people are injecting them based on influencer recommendations.
GHK-Cu is found in some cosmetic products at low concentrations, but the injectable versions being promoted online exist in a regulatory gray area. The dosing, purity, and safety profiles aren't established for human therapeutic use.
What are the actual risks here?
Berger doesn't mention potential side effects or drug interactions. Peptides can trigger immune responses, injection site reactions, and unknown long-term effects since human safety data is lacking.
For people with celiac disease, introducing foreign peptides could potentially trigger autoimmune responses, though this hasn't been studied. The gut is already inflamed in active celiac disease.
TB-500 has been flagged by WADA (World Anti-Doping Agency) as a prohibited substance because of potential performance-enhancing effects. That should tell you something about its biological activity and unknown risks.
What should people with PCOS and celiac actually know?
PCOS management has established treatments: metformin, birth control pills, spironolactone, and lifestyle changes. A 2018 Cochrane review found metformin reduced insulin resistance and improved ovulation in PCOS patients.
For celiac disease, the only proven treatment remains a strict gluten-free diet. No peptide therapy has shown benefit in clinical trials for either condition.
If you're dealing with these conditions, work with healthcare providers familiar with evidence-based treatments rather than experimenting with unregulated compounds promoted on social media.